The developer has secured full planning consent for the demolition of an old milk processing factory and development of 49 residential units and one commercial unit, pre-let to the Co-op on a 15 year lease. The residential development will comprise 39 private units (1 bed flats, 2 bed maisonettes, 3 and 4 bed houses) and 10 affordable units where a sale has already been pre-agreed. The scheme will also include car parking, cycle storage and landscaping.
days to go:
Expired
investment:
Withheld
Molecular Warehouse are trying to create a world where most diseases are prevented by giving people the chance to monitor and manage their health where ever and whenever. Molecular Warehouse have developed a platform that allows anyone to test themselves at any time.
days to go:
Expired
investment:
£737,480
Bricksave is a global platform that provides individuals with direct access to institutional-grade real estate investments previously only accessible to experienced, qualified, High Net Worth Investors. The company has a fully automated and functioning platform through which it hit the target of $4m and is aiming for the next milestone of $25m by the end of 2020. Moreover, the company has an experienced founding team of advisors backed by a successful track record. It also received a YoY growth in excess of 260%. With the proceeds, Bricksave will continue its aggressive growth strategy, boost its market position in current geographies and increase marketing efforts.
days to go:
Expired
investment:
£673,025
Gravity is a tech-based co-living brand that endeavours to create a global community of young professionals by offering living spaces. The company operates three locations in Camden Town and one in Finsbury Park with over 100 beds. The company offers design-led living spaces with all-inclusive, flexible contracts, typically between 3 to 12 months to its users. It is currently working on potential projects with strategic real estate partners in Paris, Barcelona, and Milan aiming to develop a global network of co-living spaces in major business hubs worldwide. It will use 48% of the investment as opening costs, 37% as salary payments, and 15% as marketing, legal and miscellaneous expenses.
days to go:
Expired
investment:
£265,780
Arca is helping to build the market for property market risk transfer by dealing in derivatives for domestic and commercial properties. Nick Ruddell has held senior roles for the last 30 years with banks and big interdealer brokers.
days to go:
Expired
investment:
£676,500
Agent House is an operational system and platform (OSP) offering business administration and marketing to independent property professionals for an affordable monthly licence fee.
days to go:
Expired
investment:
£66,766
Arcis Biotechnology provide nucleic acid sample preparation solutions. They have made the process of obtaining genetic material from biological samples less time consuming so it can be done in less than 3 minutes.
days to go:
Expired
investment:
£1,146,318
Assetz Exchange (AE) is a property crowdfunding platform that endeavours to break down barriers to investing in sustainable and under-supplied Buy-To-Let sectors so that investors can create a diversified property portfolio in minutes. AE argues that Buy-To-Let has hurdles, such as capital requirements, administration burden and transaction costs making it the least preferred option for average investors. It aims to change this scenario by converting properties into micro-units, allowing investors to invest as little or as much as they like, and taking care of administrative expenses. AE has launched 12 properties so far in 2020. It also concluded the purchase of four flats in a period conversion near Sefton Park in Liverpool in January 2020 for £600,000, with a plan to sell them on for £800,000. AE envisions to originate over £20 million worth of new properties in 2021. It will use the investment to expand its network of sourcing agents, build a larger credit team, invest in marketing campaigns, and increase automation wherever possible.
days to go:
Expired
investment:
£293,382
C-Major is a medical technology company. It asserts that over 2 million people suffer a Needle Stick Injury (NSI) every year and are at risk of contracting blood-borne viruses such as Hepatitis and HIV. It aspires to resolve this crisis by bringing to market its patented medical device, Controlled Helical Retraction Device, to prevent NSIs. The company argues that the device contains a ‘Helical Track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘Sealed Port’ to minimise any blood splatter. C-Major endeavours to disrupt the $5.5 billion safety syringe market with its product. It is backed by the UK 'Innovation Seed' fund. C-Major will use the investment to complete the final design of its product for manufacture and assembly ahead of a Series A funding round in 2021.
days to go:
Expired
investment:
£211,595
Please watch the video for more information
days to go:
Expired
investment:
£1,210,000
